Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

Classical Tantra is one of India's oldest contemplative traditions, predating many of the spiritual systems the world has ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

A detailed overview of NeuroSalt's five-ingredient plant-based nerve health supplement - covering botanical formula ...

On World Quantum Day, Berenice Baker examines AI's potential to accelerate quantum software development, while quantum ...

The National Institute of Standards and Technology finalized its first three post-quantum cryptography standards on August 13 ...

The silence at Old Sheldon Church Ruins is the good kind of quiet, the kind that feels full rather than empty. You can hear birds singing, leaves rustling, the occasional breeze moving through the ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Anyone who has weathered a bad stomach bug knows the feeling: a loss of appetite that sets in and lingers, even after the initial illness. For the millions of people around the world who are ...

In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...